(Q46146130)

19 December 2017

title

Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors (English)

1 reference

19 December 2017

1

Electron Kebebew

1 reference

19 December 2017

Orlo Clark

3

object named as

Orlo H Clark

1 reference

19 December 2017

author name string

Francis S Greenspan

2

1 reference

19 December 2017

Kenneth A Woeber

4

1 reference

19 December 2017

Alex McMillan

5

1 reference

19 December 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

19 December 2017

published in

Cancer

1 reference

19 December 2017

volume

103

1 reference

19 December 2017

page(s)

1330-1335

1 reference

19 December 2017

issue

7

1 reference

19 December 2017

A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns]

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20936

7 January 2021

Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20936

7 January 2021

Anaplastic carcinoma of the thyroid: a review of 84 cases of spindle and giant cell carcinoma of the thyroid

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20936

7 January 2021

The role of initial debulking surgery in the management of anaplastic thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20936

7 January 2021

A multimodality therapeutic approach in anaplastic thyroid carcinoma: study on 39 patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20936

7 January 2021

Anaplastic thyroid carcinoma: long-term survival after radical surgery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20936

7 January 2021

A combined modality for anaplastic large-cell carcinoma of the thyroid

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20936

7 January 2021

Treatment of locally advanced thyroid carcinoma with combination doxorubicin and radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20936

7 January 2021

The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20936

7 January 2021

Combination therapy for anaplastic giant cell thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20936

7 January 2021

Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20936

7 January 2021

Multimodality treatment in anaplastic giant cell thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20936

7 January 2021

Combined doxorubicin, hyperfractionated radiotherapy, and surgery in anaplastic thyroid carcinoma. Report on two protocols. The Swedish Anaplastic Thyroid Cancer Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20936

7 January 2021

Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20936

7 January 2021

Multimodal therapy in anaplastic giant cell thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20936

7 January 2021

Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20936

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.20936

1 reference

7 January 2021

Anaplastic thyroid cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20936

7 January 2021

Effect of primary treatment on survival in anaplastic thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20936

7 January 2021

Anaplastic giant-cell carcinoma of the thyroid.A study of treatment and prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20936

7 January 2021

Treatment of 37 patients with anaplastic carcinoma of the thyroid

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20936

7 January 2021

Anaplastic giant cell carcinoma of the thyroid gland: treatment and survival over a 25-year period

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20936

7 January 2021

Anaplastic thyroid carcinoma. A study of 70 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20936

7 January 2021

Anaplastic thyroid carcinoma: a 50-year experience at a single institution

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20936

7 January 2021

Anaplastic carcinoma of the thyroid: a 24-year experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20936

7 January 2021

Anaplastic carcinoma of the thyroid: A clinicopathologic study of 121 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20936

7 January 2021

Anaplastic carcinoma of the thyroid

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20936

7 January 2021

Anaplastic thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20936

7 January 2021

Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20936

7 January 2021

Combined chemotherapy with bleomycin, adriamycin, and platinum in advanced thyroid cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20936

7 January 2021

Identifiers

DOI

10.1002/CNCR.20936

1 reference

19 December 2017

PubMed ID

15739211

1 reference

19 December 2017